Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Anthony Rostron

Newcastle AuthorsTitleYearFull text
Dr Thomas Hellyer
Dr Stephen Wright
Dr Simon Baudouin
Dr Anthony Rostron
Jen Scott
et al.		Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation2020
Daniel Brooks
Dr Sarah Wiscombe
Professor John Simpson
Dr Anthony Rostron
Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation2020
Amanda Winter
Dr Will Jones
Dr Joy Allen
Dr David Price
Dr Anthony Rostron
et al.		The clinical need for new diagnostics in the identification and management of patients with suspected sepsis in UK NHS hospitals: A survey of healthcare professionals2020
Dr John Widdrington
Dr Aurora Gomez Duran
Dr Angela Pyle
Dr Marie Ruchaud-Sparagano
Jonathan Scott
et al.		Exposure of Monocytic Cells to Lipopolysaccharide Induces Coordinated Endotoxin Tolerance, Mitochondrial Biogenesis, Mitophagy, and Antioxidant Defenses2018
Dr Emma Pinder
Dr Anthony Rostron
Dr Thomas Hellyer
Dr Marie Ruchaud-Sparagano
Jonathan Scott
et al.		Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis2018
Dr John Widdrington
Dr Aurora Gomez Duran
Dr Jannetta Steyn
Dr Angela Pyle
Dr Marie Ruchaud-Sparagano
et al.		Mitochondrial DNA depletion induces innate immune dysfunction rescued by IFN-γ2017
Jonathan Scott
Dr Jim Macfarlane
Dr Thomas Hellyer
Dr Anthony Rostron
Dr Marie Ruchaud-Sparagano
et al.		Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by beta(2)-agonists, corticosteroids, and critical illness2016
Dr Hannah Walden
Dr Abigail Vallance
Danai Karamanou
Christopher Fox
Dr Anthony Rostron
et al.		The Alarmin HMGB1 Is an Inflammatory Mediator in Brain Death Induced Lung Damage2011
Dr Anthony Rostron
Dr David Cork
Vassillios Avlonitis
Professor Andrew Fisher
Professor John Dark
et al.		Contribution of Toll-Like Receptor Activation to Lung Damage After Donor Brain Death2010
Dr Hannah Walden
Danai Karamanou
Christopher Fox
Dr Anthony Rostron
Professor John Kirby
et al.		Evaluation of secretory leucoprotease inhibitor (SLPI) as an anti-inflammatroy therapy for donor lung inflammation2010
12